Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 41, Issue 3

Issues

Absence of Known Familial Hemiplegic Migraine (FHM) Mutations in the CACNA1A Gene in Patients with common Migraine: Implications for Genetic Testing

Thomas Wieser / Christoph Mueller / Stefan Evers / Stephan Zierz / Thomas Deufel
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.042

Abstract

Mutations in the gene CACNA1A have been known to cause familial hemiplegic migraine (FHM); it has been suggested, based on indirect genetic studies, that this gene may also be involved in common forms of migraine. To obtain data from direct gene analysis to test this hypothesis, we investigated 143 patients with common migraine, irrespective of their family history, for the presence of mutations known to result in the FHM phenotype; the mutations V714A, R192Q, R583Q, T666M, V1457L, and I1811L were absent in our patient sample. Furthermore, exons 4, 16, 17, and 36 were completely screened by single-strand conformation polymorphism (SSCP), and no other, hitherto unknown, mutations were detected. Bearing in mind that, in particular, the T666M mutation contributes to a large proportion of FHM linked to chromosome 19, we conclude that common migraine is distinct from FHM in its molecular basis and, therefore, most likely also in its pathophysiology. The possibility, however, of the existence of allelic disorders, with mutations located in other regions of the CACNA1A gene, cannot be ruled out. Molecular testing, therefore, is at present not a feasible option for the diagnosis and classification of migraine.

About the article

Published Online: 2005-06-01

Published in Print: 2003-03-24


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 41, Issue 3, Pages 272–275, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.042.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
S. Stuart and L. R. Griffiths
Molecular Genetics and Genomics, 2012, Volume 287, Number 11-12, Page 837
[2]
Maija Wessman, Gisela M Terwindt, Mari A Kaunisto, Aarno Palotie, and Roel A Ophoff
The Lancet Neurology, 2007, Volume 6, Number 6, Page 521
[3]
Stefano Gerola, Stefania Battistini, Stefania Stenirri, Maria Nicolodi, Graziano Arnetoli, Stefania Canova, Giorgio Binelli, Alberto Bernardi, Simona Balan, Maurizio Ferrari, and Paola Carrera
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 6
[4]
Pasquale Montagna
Expert Review of Neurotherapeutics, 2008, Volume 8, Number 9, Page 1321
[5]
F Fernandez, NJ Colson, and LR Griffiths
Pharmacogenomics, 2007, Volume 8, Number 6, Page 609
[6]
Robert W. Baloh
Headache Currents, 2006, Volume 3, Number 1, Page 1
[7]
Thomas Wieser, Julio Pascual, Agusto Oterino, Michael Soso, Michael Barmada, and Kathy L. Gardner
Headache: The Journal of Head and Face Pain, 2010, Volume 50, Number 6, Page 955
[8]
Mari A. Kaunisto, Päivi J. Tikka, Mikko Kallela, Suzanne M. Leal, Jeanette C. Papp, Arja Korhonen, Eija Hämäläinen, Hanna Harno, Hannele Havanka, Markku Nissilä, Erkki Säkö, Matti Ilmavirta, Jaakko Kaprio, Markus Färkkilä, Roel A. Ophoff, Aarno Palotie, and Maija Wessman
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005, Volume 132B, Number 1, Page 85
[9]
Malene Kirchmann, Lise Lykke Thomsen, and Jes Olesen
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006, Volume 141B, Number 3, Page 250
[10]
Pasquale Montagna
Neurological Sciences, 2008, Volume 29, Number S1, Page 47
[11]
JM Hansen, LL Thomsen, J Olesen, and M Ashina
Cephalalgia, 2008, Volume 28, Number 5, Page 496
[12]
Pasquale Montagna
The Journal of Headache and Pain, 2008, Volume 9, Number 2, Page 57
[13]
JM Hansen, LL Thomsen, R Marconi, G Casari, J Olesen, and M Ashina
Cephalalgia, 2008, Volume 28, Number 4, Page 367
[14]
Desiree M. Fernandez, Collette K. Hand, Brian J. Sweeney, and Nollaig A. Parfrey
Headache: The Journal of Head and Face Pain, 2007, Volume 0, Number 0, Page 070623002213004
[15]
J. Haan, E. E. Kors, Kaate R. J. Vanmolkot, Arn M. J. M. Maagdenberg, Rune R. Frants, and M. D. Ferrari
Current Pain and Headache Reports, 2005, Volume 9, Number 3, Page 213
[16]
Esther E Kors, Kaate RJ Vanmolkot, Joost Haan, Rune R Frants, Arn MJM van den Maagdenberg, and Michel D Ferrari
Current Opinion in Neurology, 2004, Volume 17, Number 3, Page 283

Comments (0)

Please log in or register to comment.
Log in